title: Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo.
abstract: Suberoylanilide hydroxamic acid (SAHA; vorinostat), the second generation of histone deacetylase (HDAC) inhibitor, has been approved for the treatment of cutaneous manifestations of cutaneous T cell lymphoma (CTCL). It has also shown its anticancer activity over a large range of other hematological and solid malignancies, but few studies have been reported in B cell lymphoma. In this study, we aimed to investigate the antitumor activity of SAHA on murine B cell lymphoma cell line A20 cells. We treated A20 cells with different concentrations of SAHA. The effect of SAHA on the proliferation of A20 cells was studied by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) assay in vitro; the anti-proliferation activity in vivo was evaluated by proliferating cell nuclear antigen (PCNA) of xenograft tumor tissues through immunocytochemical staining. Apoptosis were detected by Hoechst 33258 staining and Annexin V/propidium iodide (PI) double-labeled cytometry in vitro. The effect of SAHA on cell cycle of A20 cells was studied by a propidium iodide method. Autophagic cell death induced by SAHA was confirmed by transmission electron microscopy (TEM). Angiogenesis marker (CD31) was measured by immunocytochemical staining to investigate the anti-angiogenic effect of SAHA. Western blot was used to detect the expression of signaling pathway factors (phospho-AKT, phospho-ERK, AKT, ERK, Nur77, HIF-1α, and VEGF). Our results showed that SAHA inhibited the proliferation of A20 cells in a time- and dose-dependent manner, induced cell apoptosis and G0/G1 phase arrest of cell cycle, promoted autophagic cell death, and suppressed tumor progress in NCI-A20 cells nude mice xenograft model in vivo. SAHA decreased the activation of AKT (phospho-AKT: p-AKT) and ERK1/2 (phospho-ERK: p-ERK) proteins and inhibited the expression of pro-angiogenic factors (VEGF and HIF-1α), downregulated its downstream signaling factor (Nur77), which might be contributed to the antitumor mechanisms of SAHA.
authors: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.
authors: Bohan
authors: B
authors: Yang
authors: Dandan
authors: D
authors: Yu
authors: Jingwen
authors: J
authors: Liu
authors: Kunyu
authors: K
authors: Yang
authors: Gang
authors: G
authors: Wu
authors: Hongli
authors: H
authors: Liu
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017209:Apoptosis / Q000187:drug effects; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects*; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage*; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D000077337:Vorinostat; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D000077337:Vorinostat
references: Cytokine. 2014 Dec;70(2):87-96
references: 25127907
references: Virology. 2009 Mar 1;385(1):192-7
references: 19135224
references: Biochim Biophys Acta. 2010 Sep;1803(9):1106-13
references: 20595063
references: Biochim Biophys Acta. 2012 Mar;1819(3-4):238-46
references: 21763476
references: Biochem Biophys Res Commun. 2008 May 16;369(4):1179-83
references: 18342621
references: Cell Cycle. 2006 Nov 1;5(21):2430-5
references: 17102633
references: Cell Death Differ. 2000 Mar;7(3):262-71
references: 10745271
references: Trends Endocrinol Metab. 2014 Dec;25(12):620-7
references: 25242548
references: PLoS One. 2009 Dec 14;4(12):e8283
references: 20011539
references: Trends Pharmacol Sci. 2014 Nov;35(11):583-91
references: 25270767
references: Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14639-44
references: 20679231
references: Oncogene. 2002 Jan 17;21(3):427-36
references: 11821955
references: FEBS Lett. 2010 Apr 2;584(7):1427-35
references: 20035753
references: Radiother Oncol. 2009 Sep;92(3):323-8
references: 19541381
references: World J Urol. 1996;14(3):166-74
references: 8806195
references: J Hematol Oncol. 2009 Jul 27;2:31
references: 19635146
references: Eur J Cancer. 2012 May;48(7):1096-107
references: 22154545
references: Oncogene. 2007 Feb 26;26(9):1351-6
references: 17322921
references: Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16090-5
references: 16243973
references: Biomed Res Int. 2014;2014:231012
references: 24707477
references: Cancer Lett. 2008 Sep 28;269(1):7-17
references: 18462867
references: Bioorg Med Chem Lett. 2010 Nov 15;20(22):6816-9
references: 20855208
references: Oncologist. 2007 Oct;12(10):1247-52
references: 17962618
references: Blood. 2008 Feb 1;111(3):1060-6
references: 17962510
references: J Exp Med. 2006 Mar 20;203(3):719-29
references: 16520388
references: Acta Neuropathol. 2013 Dec;126(6):793-807
references: 23912309
references: Blood. 2014 Apr 10;123(15):2367-77
references: 24553175
references: Genes Dev. 1999 Nov 15;13(22):2905-27
references: 10579998
references: Plant Cell Rep. 2013 Oct;32(10):1625-36
references: 23820978
references: Cell Death Differ. 2003 Apr;10(4):400-3
references: 12719715
references: Cell. 2007 Feb 23;128(4):693-705
references: 17320507
references: J Biol Chem. 2005 Nov 18;280(46):38879-87
references: 16186112
references: Autophagy. 2010 Aug;6(6):711-24
references: 20543569
references: Cell. 2007 Feb 23;128(4):721-33
references: 17320509
references: J Gastrointest Cancer. 2008;39(1-4):149-58
references: 19373441
references: J Neurol Sci. 2003 Nov 15;215(1-2):57-62
references: 14568129
references: Clin Lymphoma Myeloma Leuk. 2010 Apr;10(2):149-51
references: 20371450
references: Biochimie. 2006 Mar-Apr;88(3-4):297-307
references: 16216405
references: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):673-8
references: 15637150
references: Cell Signal. 2013 Dec;25(12):2530-9
references: 23993957
references: Cell Death Differ. 2006 Jan;13(1):129-40
references: 15947789
references: Biologics. 2013;7:47-60
references: 23459471
references: Biochim Biophys Acta. 2009 Sep;1793(9):1516-23
references: 19167434
references: Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18030-5
references: 15596714
references: Biochim Biophys Acta. 2015 Feb;1852(2):252-61
references: 24882754